Skip to content

Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya

Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05609786
Acronym
myPlanKenya
Enrollment
440
Registered
2022-11-08
Start date
2022-06-22
Completion date
2025-04-19
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Violence, Domestic, Violence, Gender-Based, Violence, Sexual

Keywords

Intimate Partner Violence, Relationships, Safety Planning, technology, implementation

Brief summary

This effectiveness-implementation hybrid-3 study evaluates dissemination, implementation, and effectiveness of myPlanKenya. myPlanKenya will be disseminated through formal and informal sectors. This clinical trial portion of the study enrolls women at risk for intimate partner violence (IPV) who are referred to myPlanKenya by disseminators (i.e. "end-users"). This trial aims to evaluate the effectiveness of myPlanKenya referral on resilience, health and safety among a cohort of women referred to myPlanKenya based on disclosure of IPV or assessed to have IPV related risks.

Interventions

BEHAVIORALPersonalized safety planning tool

The myPlan Kenya app is a web-based safety planning tool that is secure, private, free and personalized to the user. The app includes multiple, evidence-based modules: Strategies (safety strategies tailored to the user's needs and violence experience); Resources (referrals to local health, safety and justice resources and services); About You (questionnaires that help the user assess their relationship safety and tailor their Strategies, including My Relationship, Red Flags, My Safety, My Priorities); Understanding (knowledge sections that share information on relationships and violence, including Healthy Relationships, Harmful Beliefs About Abuse, About Violence).

Sponsors

Johns Hopkins Bloomberg School of Public Health
Lead SponsorOTHER
Ujamaa Africa
CollaboratorUNKNOWN
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female * Age 16 or older * Physical or sexual partner violence or relationship-based fears within the past six months; behaviorally assessed * Living in Nairobi, Kenya with no plans to move in the next 12 months * Access to a safe smart phone or computer (personal or shared), and comfort using it to access the myPlan Kenya app * Literate in English or Swahili languages; confirmed by reading and completing a short passage by filling in several blanks with the appropriate words, selected from a drop-down menu.

Exclusion criteria

* Male * Under age 16 * Have not experienced physical or sexual partner violence or relationship-based fears in past 6 months * Lives outside of the study area or plans to move within the next 12 months * Does not have access to a safe smart phone or computer, or is uncomfortable using it to access the myPlan Kenya app * Illiterate in English or Swahili languages

Design outcomes

Primary

MeasureTime frameDescription
Resilience as Assessed by Connor-Davidson Resilience ScaleBaseline, 6-month, 12-month10-item Connor-Davidson Resilience Scale assesses resilience using a 5-point Likert scale (0-4). Scored from 0-40, with higher scores indicating greater resilience and lower scores indicating lower resilience.
Decisional Conflict ScoreBaseline, 6-month, 12-month12-item decisional conflict measures (specific to safety), assessed using a 5-point Likert scale (0-4). The mean Decisional Conflict score is multiplied by 25 to create an overall score, ranging from 0-100; 0 (no decisional conflict) to 100 (extremely high decisional conflict).
Safety/IPV Experience(s) as Assessed by the Conflict Tactics Scale-2Baseline, 6-month, 12-month10-item adapted Conflict Tactics Scale-2 (CTS2), which assesses IPV experiences using a 3-point scale on the frequency of these experiences. Score range 0-20; higher score indicates more IPV.
Percentage of Participants Who Sought Services (Help-seeking)Baseline, 6-month, 12-month6-item index on help-seeking, which assesses abuse disclosure and services/information received on a 2-point scale (yes/no); operationally defined as percentage of participants who sought help from any of the services.
Helpfulness of Services Assessed by Help-Seeking IndexBaseline, 6-month, 12-month6-item index on help-seeking which assesses abuse disclosure and services/information. Helpfulness of services rated on a 5-point Likert scale (Score range 0-4; with higher score more helpful). Mean helpfulness score of services sought is reported.

Secondary

MeasureTime frameDescription
Safety Strategy ScoreBaseline, 6-month, 12-month5-item index on safety strategies used (yes/no), summed for a range of 0-5 with higher scores indicating more safety strategies used. For each strategy used, helpfulness is assessed on a 5-point Likert scale (1-5), with higher scores indicating more helpfulness; mean scores are presented (range 1-5).
IPV Recognition as Assessed by the Abusive Behaviors ScaleBaseline, 6-month, 12-month7-item adapted Abusive Behaviors Scale, which assesses IPV recognition using a 5-point Likert scale (0-4). Items are scored from 0-28, with higher scores indicating greater IPV recognition and lower scores indicating lower IPV recognition.

Countries

Kenya

Contacts

PRINCIPAL_INVESTIGATORMichele Decker

Johns Hopkins Bloomberg School of Public Health

Participant flow

Recruitment details

This single arm implementation trial enrolled 440 women referred to the myPlanKenya safety decision aid. Individuals were eligible for 12-month follow-up irrespective of 6-month completion.

Baseline characteristics

Characteristic
Age, Customized
18-24 years
186 Participants
Age, Customized
<18 years
4 Participants
Age, Customized
25-34 years
159 Participants
Age, Customized
35-44 years
76 Participants
Age, Customized
>=45 years
14 Participants
Educational Attainment
Primary
39 Participants
Educational Attainment
Secondary
204 Participants
Educational Attainment
Some secondary
37 Participants
Educational Attainment
University or beyond
47 Participants
Educational Attainment
Vocational training
107 Participants
Race/Ethnicity, Customized
Kamba
60 Participants
Race/Ethnicity, Customized
Kikuyu
103 Participants
Race/Ethnicity, Customized
Luhya
62 Participants
Race/Ethnicity, Customized
Luo
147 Participants
Race/Ethnicity, Customized
Other
66 Participants
Sex: Female, Male
Female
440 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 440
other
Total, other adverse events
0 / 440
serious
Total, serious adverse events
0 / 440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026